Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Korea S.E.
2026-09-02
|
5-day change | 1st Jan Change | ||
| 5,630.00 KRW | -4.41% |
|
+6.03% | -17.45% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.05x | - | 19.98x | - | 102M | ||
| -234.01x | 23.88x | 23.83x | 15.55x | -278.7x | -203.49x | -.--% | 46.24B | ||
| 23.51x | 2.96x | 0.71x | 2.15x | 12.15x | 14.9x | 0.89% | 26.57B | ||
| 16.02x | 1.11x | 1.07x | 1.26x | 7.18x | 13.18x | 5.47% | 6.94B | ||
| 1078.86x | - | -8.43x | - | - | - | - | 5.94B | ||
| 51.51x | 11.15x | 2.38x | 9.49x | 32.7x | 40.6x | 0.97% | 3.35B | ||
| -25.28x | - | -0.07x | - | - | - | - | 2.53B | ||
| -58.45x | - | 0.91x | - | - | - | -.--% | 2.24B | ||
| 14.5x | 2x | 0.79x | 1.47x | 5.77x | 9.63x | 5.25% | 2.03B | ||
| 30.88x | 1.78x | -0.09x | 1.63x | 12.2x | 20.8x | 1.46% | 1.88B | ||
| 25.62x | 1.71x | 0.03x | 1.05x | 8.4x | 12.22x | 0.84% | 1.67B | ||
| 68.69x | 13.27x | 2.29x | 15.2x | 36.07x | 47.78x | 0.11% | 1.63B | ||
| 41.65x | 1.49x | -1.49x | 0.88x | 7.44x | 25.34x | 3.42% | 1.26B | ||
| -6.8x | 0.66x | 0.27x | 1.25x | - | -4.52x | - | 1.13B | ||
| 45.01x | 14.79x | 1.6x | - | - | - | 1.86% | 991M | ||
| 28.5x | 2.14x | 1.11x | - | - | - | 0.34% | 885M | ||
| 18.41x | 1.06x | -14.47x | - | - | - | 3.38% | 866M | ||
| 19.23x | 1.27x | 0.18x | 1.47x | 6.92x | 12.14x | 3.96% | 624M | ||
| Average | 66.93x | 5.66x | 0.62x | 4.45x | -14.99x | 0.71x | 2% | 5.94B | |
| Weighted average by Cap. | -31.00x | 13.33x | 10.13x | 9.13x | -133.24x | -91.97x | 0.94% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















